Table 3. Prediction of Nonremission in MDD Patients at Baseline.

Features used in prediction model	Initial cohort (genes only)	Validation cohort (genes only)
# features used in model	13	6
Corrected accuracy (%)	79.4	76.2
Sensitivity (%)	66.7	86.1
Specificity (%)	89.5	59.3

Accuracy represents the percentage of correctly identified samples. Sensitivity represents the ability to predict nonremission. Specificity represents the ability to predict remission. The corrected accuracy was obtained by nested cross-validation approach as described in Figure 2.